September 21, 2020
We want to make this clear right off the bat: APhA is steadfastly opposed to sexism, racism, discrimination, harassment, and intimidation – implicit or explicit – and we are committed to combatting behaviors that undermine any member of our profession.
September 14, 2020
The American Pharmacists Association (APhA) announced today that it has named Antonio Ciaccia, Chief Strategy Officer of 3 Axis Advisors, as APhA’s Senior Advisor for Disruptive Innovation and Practice Transformation. This addition will supercharge the association’s efforts to disrupt our broken payment models and drive the profession of pharmacy forward. Antonio begins his duties immediately.
September 14, 2020
The American Pharmacists Association (APhA) announced today that it has named Rafael Saenz, PharmD, MS, FASHP, as Chief of Staff of the association. Dr. Saenz will have oversight for membership and member relations, health systems and international strategy, meetings and expositions, publications and periodicals, communications and marketing, and creative services.
September 9, 2020
The U.S. Department of Health and Human Services (HHS) today authorized pharmacists and pharmacist interns to order and administer COVID-19 vaccines that have been approved or licensed by the Food and Drug Administration (FDA) to all individuals age 3 or older. Pharmacist interns must do so while acting under the supervision of qualified pharmacist.
APhA, 12 Other Pharmacy Organizations Call for Tier 1 Priority Status for Pharmacists in Planning for the COVID-19 Vaccine
September 4, 2020
The American Pharmacists Association and 12 other pharmacy organizations today told a special committee of the National Academies of Science, Engineering and Medicine (NASEM) that pharmacists should be given tier 1 priority status in the allocation and distribution of COVID-19 vaccine(s).
September 3, 2020
All pharmacists should be in the first tier of providers for receiving the COVID-19 vaccine to ensure that pharmacists are able to continue providing critical care to their patients, said Scott J. Knoer, MS, PharmD, FASHP, in testimony this week to a committee of the National Academies of Science, Engineering and Medicine.
August 21, 2020
There are no greater public health priorities today than defeating the COVID-19 pandemic and protecting our nation from other vaccine-preventable diseases like the seasonal flu. We need all hands on deck to improve Americans’ access to life-saving vaccines during these difficult times.
In Major Win, HHS Authorizes Pharmacists to Order and Administer Vaccines to Children Nationwide During the Public Health Emergency
August 19, 2020
The American Pharmacists Association applauds today’s announcement by the U.S. Department of Health and Human Services, which authorizes licensed pharmacists to provide all vaccines recommended by the CDC’s Advisory Committee on Immunization Practices (ACIP), and approved or licensed by the FDA, to all children ages 3 to 18 during the COVID-19 pandemic, regardless of state laws and regulations to the contrary.
Dangers of Mandatory Mail Order Shine Light on the Need for Patient Pharmacy Choice and Protecting the Pharmacist-Patient Relationship
August 18, 2020
The American Pharmacists Association (APhA) is deeply concerned about anecdotal reports of disruptions in the US Postal Service delivery of medications to our members’ patients, including our nation’s veterans. While we are working to independently determine the full extent of these reported interruptions, it is crucial to note that missing medication doses can have a significant impact on a patient’s health.
APhA: Transparency, Safety and Availability Must Be Core Principles for Strengthening America’s Drug Supply Chain
August 10, 2020
The reliability, quality and safety of our nation’s drug supply chain are essential to the nation’s security and health and well-being of the American public. Therefore, we welcome comprehensive federal efforts to improve the state of our drug supply chain, particularly at a time when our health care system is under extraordinary stress.